• 中国精品科技期刊
  • 《中文核心期刊要目总览》收录期刊
  • RCCSE 中国核心期刊(5/114,A+)
  • Scopus收录期刊
  • 美国《化学文摘》(CA)收录期刊
  • WHO 西太平洋地区医学索引(WPRIM)收录期刊
  • 《中国科学引文数据库(CSCD)》核心库期刊 (C)
  • 中国科技核心期刊
  • 中国科技论文统计源期刊
  • 《日本科学技术振兴机构数据库(中国)》(JSTChina)收录期刊
  • 美国《乌利希期刊指南》(UIrichsweb)收录期刊
  • 中华预防医学会系列杂志优秀期刊(2019年)

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

自身免疫性疾病流行病学研究进展

方心宇 冷瑞雪 范引光 张勤 潘海峰 叶冬青

方心宇, 冷瑞雪, 范引光, 张勤, 潘海峰, 叶冬青. 自身免疫性疾病流行病学研究进展[J]. 中华疾病控制杂志, 2021, 25(8): 869-873. doi: 10.16462/j.cnki.zhjbkz.2021.08.001
引用本文: 方心宇, 冷瑞雪, 范引光, 张勤, 潘海峰, 叶冬青. 自身免疫性疾病流行病学研究进展[J]. 中华疾病控制杂志, 2021, 25(8): 869-873. doi: 10.16462/j.cnki.zhjbkz.2021.08.001
FANG Xin-yu, LENG Rui-xue, FAN Yin-guang, ZHANG Qin, PAN Hai-feng, YE Dong-qing. Research advances in the epidemiology of autoimmune diseases[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(8): 869-873. doi: 10.16462/j.cnki.zhjbkz.2021.08.001
Citation: FANG Xin-yu, LENG Rui-xue, FAN Yin-guang, ZHANG Qin, PAN Hai-feng, YE Dong-qing. Research advances in the epidemiology of autoimmune diseases[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(8): 869-873. doi: 10.16462/j.cnki.zhjbkz.2021.08.001

自身免疫性疾病流行病学研究进展

doi: 10.16462/j.cnki.zhjbkz.2021.08.001
基金项目: 

国家自然科学基金 82073652

国家自然科学基金 81872693

国家自然科学基金 81673258

详细信息
    通讯作者:

    叶冬青,E-mail: ydq@ahmu.edu.cn

  • 中图分类号: R593.2

Research advances in the epidemiology of autoimmune diseases

Funds: 

National Natural Science Foundation of China 82073652

National Natural Science Foundation of China 81872693

National Natural Science Foundation of China 81673258

More Information
  • 摘要: 自身免疫性疾病(autoimmune diseases, AIDs)是由免疫系统对自身抗原失去免疫耐受,进一步诱发组织损伤和炎症反应并最终导致靶器官受损的一类慢性疾病。这类疾病确切的病因及发病机制至今未明,目前尚不能彻底治愈,极大地影响了患者的劳动力和生活质量,甚至威胁患者生命,消耗大量卫生资源,已成为影响人类健康的重要的公共卫生问题。在过去几十年,AIDs的流行病学研究取得了有目共睹的成就,极大促进了AIDs的诊断、治疗、预后及病因研究。本文对AIDs的流行病学研究进展进行了概述,旨在为AIDs防控策略的制定及未来的研究方向提供一些新的见解和参考。
  • [1] Zhang X, Liu C, Nepal S, et al. A hybrid approach for scalable sub-tree anonymization over big data using MapReduce on cloud[J]. J Comput Syst Sci, 2014, 80(5): 1008-1020. DOI: 10.1016/j.jcss.2014.02.007.
    [2] Theofilopoulos AN, Kono DH, Baccala R. The multiple pathways to autoimmunity[J]. Nat Immunol, 2017, 18(7): 716-724. DOI: 10.1038/ni.3731.
    [3] Chang C. Autoimmunity: from black water fever to regulatory function[J]. J Autoimmun, 2014, 48-49: 1-9. DOI: 10.1016/j.jaut.2013.12.019.
    [4] 叶冬青. 红斑狼疮[M]. 北京: 人民卫生出版社, 2006.

    Ye DQ. Lupus erythematosus[M]. Beijing: People's Medical Publishing House, 2006.
    [5] 叶冬青, 倪进发, 郑惠玲, 等. 安徽省准南市潘集区常见结缔组织病的流行病学调查. [J]. 中国人兽共患病杂志, 1993, 9: 14-15.

    Ye DQ, Ni JF, Zheng HL, et al. Epidemiological survey of common connective tissue diseases in Panji District, Zhunnan City, Anhui Province. [J]. Chin J Zoohoses, 1993, 9: 14-15.
    [6] Maahs DM, West NA, Lawrence JM, et al. Epidemiology of type 1 diabetes[J]. Endocrinol Metab Clin North Am, 2010, 39(3): 481-497. DOI: 10.1016/j.ecl.2010.05.011.
    [7] Darwish MJ, Armenian HK. A case-control study of rheumatoid arthritis in Lebanon[J]. Int J Epidemiol, 1987, 16(3): 420-424. DOI: 10.1093/ije/16.3.420.
    [8] Zou YF, Feng CC, Zhu JM, et al. Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province[J]. Rheumatol Int, 2014, 34(3): 347-356. DOI: 10.1007/s00296-013-2902-1.
    [9] 叶冬青. 皮肤病流行病学[M]. 北京: 人民卫生出版社, 2001.

    Ye DQ. Skin epidemiology[M]. Beijing: People's Medical Publishing House, 2001.
    [10] Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus[J]. Nat Genet, 2009, 41(11): 1234-1237. DOI: 10.1038/ng.472.
    [11] Leng RX, Di DS, Ni J, et al. Identification of new susceptibility loci associated with rheumatoid arthritis[J]. Ann Rheum Dis, 2020, 79(12): 1565-1571. DOI: 10.1136/annrheumdis-2020-217351.
    [12] Wu J, Zhang TP, Zhao YL, et al. Decreased H19, GAS5, and linc0597 expression and association analysis of related gene polymorphisms in rheumatoid arthritis[J]. Biomolecules, 2019, 10(1): 55. DOI: 10.3390/biom10010055.
    [13] Tahvildari M, Dana R. Low-Dose IL-2 therapy in transplantation, autoimmunity, and inflammatory diseases[J]. J Immunol, 2019, 203(11): 2749-2755. DOI: 10.4049/jimmunol.1900733.
    [14] Murdaca G, Tonacci A, Negrini S, et al. Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications[J]. autoimmun Rev, 2019, 18(9): 102350. DOI: 10.1016/j.autrev.2019.102350.
    [15] Li H, Hu F, Zhang Y, et al. Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network Meta-analysis[J]. J Neurol, 2020, 267(12): 3489-3498. DOI: 10.1007/s00415-019-09395-w.
    [16] Samoilova IG, Rotkank MA, Kudlay DA, et al. A prognostic model of cognitive impairment in patients with type 1 diabetes mellitus[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2020, 120(3): 19-22. DOI: 10.17116/jnevro202012003119.
    [17] Norgeot B, Glicksberg BS, Trupin L, et al. Assessment of a deep learning model based on electronic health record data to forecast clinical outcomes in patients with rheumatoid arthritis[J]. JAMA Netw Open, 2019, 2(3): e190606. DOI: 10.1001/jamanetworkopen.2019.0606.
  • 加载中
计量
  • 文章访问数:  191
  • HTML全文浏览量:  137
  • PDF下载量:  530
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-06-28
  • 修回日期:  2021-07-17
  • 网络出版日期:  2021-08-24
  • 刊出日期:  2021-08-10

目录

    /

    返回文章
    返回